The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.

Cancers (Basel) · 2021 · PMC7828646 · PMID 33466626

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The high-throughput screening (HTS) of several novel conventional small molecule inhibitors and phytochemicals targeting FN3K is highly significant and contributes to the development of novel inhibitors for targeting oncogenic Nrf2-driven cancers.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.